Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 496

Related Citations for PubMed (Select 9696028)

1.

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.

Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, Schmidt P, Pakrasi A, Artinian L, Murray NG, Imagawa DK, Holt C, Goldstein LI, Stribling R, Busuttil RW.

Hepatology. 1998 Aug;28(2):585-9.

PMID:
9696028
2.

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P.

Liver Transpl. 2000 Nov;6(6):741-8.

3.

Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.

Karasu Z, Ozacar T, Akyildiz M, Demirbas T, Arikan C, Kobat A, Akarca U, Ersoz G, Gunsar F, Batur Y, Kilic M, Tokat Y.

Antivir Ther. 2004 Dec;9(6):921-7.

PMID:
15651751
4.

Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.

Seehofer D, Rayes N, Steinmüller T, Müller AR, Jonas S, Settmacher U, Neuhaus R, Berg T, Neuhaus P.

Z Gastroenterol. 2002 Sep;40(9):795-9.

PMID:
12215948
5.
6.

Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.

Tchervenkov JI, Tector AJ, Barkun JS, Sherker A, Forbes CD, Elias N, Cantarovich M, Cleland P, Metrakos P, Meakins JL.

Ann Surg. 1997 Sep;226(3):356-65; discussion 365-8.

7.

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.

Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR.

Liver Transpl Surg. 1999 Nov;5(6):491-6.

PMID:
10545536
8.

Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin.

McCaughan GW, Spencer J, Koorey D, Bowden S, Bartholomeusz A, Littlejohn M, Verran D, Chui AK, Sheil AG, Jones RM, Locarnini SA, Angus PW.

Liver Transpl Surg. 1999 Nov;5(6):512-9.

PMID:
10545540
9.

Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.

Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, McCaughan GW; Australasian Liver Transplant Study Group.

Gastroenterology. 2007 Mar;132(3):931-7. Epub 2007 Jan 5.

PMID:
17383422
10.

Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.

Ołdakowska-Jedynak U, Paczek L, Foroncewicz B, Mucha K, Nyckowski P, Zieniewicz K, Ziarkiewicz-Wróblewska B, Ziółkowski J, Pilecki T, Patkowski W, Górnicka B, Paczkowska A, Krawczyk M.

Ann Transplant. 2007;12(3):28-32.

PMID:
18290567
11.

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.

Dodson SF, de Vera ME, Bonham CA, Geller DA, Rakela J, Fung JJ.

Liver Transpl. 2000 Jul;6(4):434-9.

12.

Evolving experience of hepatitis B virus prophylaxis in liver transplantation.

Honaker MR, Shokouh-Amiri MH, Vera SR, Alloway RR, Grewal HP, Hardinger KL, Kizilisik AT, Bagous T, Trofe J, Stratta RJ, Egidi MF, Gaber AO.

Transpl Infect Dis. 2002 Sep;4(3):137-43.

PMID:
12421458
13.
14.

Lamivudine for hepatitis B in liver transplantation: a single-center experience.

Malkan G, Cattral MS, Humar A, Al Asghar H, Greig PD, Hemming AW, Levy GA, Lilly LB.

Transplantation. 2000 Apr 15;69(7):1403-7.

PMID:
10798762
15.

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin.

Yoshida EM, Erb SR, Partovi N, Scudamore CH, Chung SW, Frighetto L, Eggen HJ, Steinbrecher UP.

Liver Transpl Surg. 1999 Nov;5(6):520-5.

PMID:
10545541
16.
17.

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

Perrillo RP, Wright T, Rakela J, Levy G, Schiff E, Gish R, Martin P, Dienstag J, Adams P, Dickson R, Anschuetz G, Bell S, Condreay L, Brown N; Lamivudine North American Transplant Group.

Hepatology. 2001 Feb;33(2):424-32.

PMID:
11172345
18.

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

Naoumov NV, Lopes AR, Burra P, Caccamo L, Iemmolo RM, de Man RA, Bassendine M, O'Grady JG, Portmann BC, Anschuetz G, Barrett CA, Williams R, Atkins M.

J Hepatol. 2001 Jun;34(6):888-94.

PMID:
11451173
19.

Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis.

Lo CM, Cheung ST, Lai CL, Liu CL, Ng IO, Yuen MF, Fan ST, Wong J.

Ann Surg. 2001 Feb;233(2):276-81.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk